Organization · Venture Capital
Averis Ventures
Averis Ventures is an early-stage investment firm based in Israel, focusing on transformative healthcare companies, particularly in deep life sciences and health technology. The firm aims to bridge the funding gap for innovative healthcare startups that face technical and regulatory complexities.
Overview
What Averis Ventures does
What Averis Ventures is
Averis Ventures is an early-stage investment firm based in Israel, focusing on transformative healthcare companies, particularly in deep life sciences and health technology. The firm aims to bridge the funding gap for innovative healthcare startups that face technical and regulatory complexities.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 4, 2026
Official channels
Find Averis Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Averis Ventures as a funder
Investment thesis
Averis Ventures focuses on investing in early-stage healthcare companies, particularly those in Israel, that face underfunding due to their technical and regulatory complexities. The firm aims to engage with clinical and regulatory realities from inception, leveraging relationships in the DACH corridor to access competitive investment opportunities.
Focus narrative
Averis Ventures invests in sectors including Deep Life Science & GenBio, which encompasses therapeutics, AI-native biology, and diagnostics; Bio-Enabled Platforms & Infrastructure, focusing on drug discovery tools and bio-manufacturing; and HealthTech, which includes clinical enablement and regulated care infrastructure. The firm strategically operates within the DACH healthcare ecosystem, providing access to high-quality investment opportunities.
Value beyond capital
Averis Ventures adds value to its portfolio companies by engaging early with clinical realities and regulatory considerations, ensuring that investments are well-positioned to navigate the complexities of the healthcare landscape. The firm's strong relationships within the DACH corridor further enhance its ability to access competitive investment rounds.
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- DACH
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
As of now, no specific portfolio companies have been publicly disclosed.
Common questions
What to know about Averis Ventures
Upseed classifies Averis Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.